Lysoway Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $3.4M

  • Investors
  • 4

Lysoway Therapeutics General Information

Description

Developer of a lysosomal ion research platform designed to address neurodegenerative diseases and metabolic storage disorders. The company's tool offers technological approaches to screen and develop potent modulators of lysosomal ion channels, including both lysosomal ion channels that can restore autophagic flux and resolution, as well as improve plasma membrane repair through direct activation of lysosomal exocytosis, enabling healthcare providers to treat neurodegenerative diseases with genetic defects.

Contact Information

Website
www.lysoway.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 125 Cambridgepark Drive
  • Suite 301
  • Cambridge, MA 02140
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 125 Cambridgepark Drive
  • Suite 301
  • Cambridge, MA 02140
  • United States

Lysoway Therapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lysoway Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Jul-2026 $3.4M Completed Clinical Trials - Phase 1
2. Grant 05-Aug-2025 Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 05-Oct-2022 $22M $22M Completed Clinical Trials - General
To view Lysoway Therapeutics’s complete valuation and funding history, request access »

Lysoway Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Michael J. Fox Foundation Limited Partner
3E Bioventures Capital Venture Capital Minority
Highlight Capital Venture Capital Minority
Oceanpine Capital Growth/Expansion Minority
To view Lysoway Therapeutics’s complete investors history, request access »

Lysoway Therapeutics FAQs

  • When was Lysoway Therapeutics founded?

    Lysoway Therapeutics was founded in 2020.

  • Where is Lysoway Therapeutics headquartered?

    Lysoway Therapeutics is headquartered in Cambridge, MA.

  • What industry is Lysoway Therapeutics in?

    Lysoway Therapeutics’s primary industry is Drug Discovery.

  • Is Lysoway Therapeutics a private or public company?

    Lysoway Therapeutics is a Private company.

  • What is Lysoway Therapeutics’s current revenue?

    The current revenue for Lysoway Therapeutics is .

  • How much funding has Lysoway Therapeutics raised over time?

    Lysoway Therapeutics has raised $22M.

  • Who are Lysoway Therapeutics’s investors?

    Michael J. Fox Foundation, 3E Bioventures Capital, Highlight Capital, and Oceanpine Capital have invested in Lysoway Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process